• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED - Corporate Spotlight

0.00% ! 30.5¢
Market Cap $445.4M  !
Healthcare Biotechnology
Add to My Watchlist

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
30.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $445.4M
Open High Low Value Volume
31.0¢ 31.0¢ 30.0¢ $817.0K 2.675M

Buyers (Bids)

No. Vol. Price($)
8 174362 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 8211 1
View Market Depth
Last trade - 16.10pm 19/05/2025 (20 minute delay) ?
IMM (ASX) Chart

Top Stories

Gravity data proves fruitful in gold targeting for Accelerate

Accelerate Resources Ltd has been able to define a new and high value gold target for upcoming drilling, based on this data
ASX Market Open: Local bourse set to rise after US panic melts away Good Morning and welcome to HotCopper’s Market Open, I’m Jon Davidson.The local bourse is set to rise after Wall Street overnight largely shrugged off panic borne from Moody’s credit downgrade for the US over the weekend. Only the Russell 2000 ended...
Uvre dives into gold with 'transformational' acquisition in New Zealand Uvre Ltd is set to acquire a portfolio of gold projects in New Zealand, including the Waitekauri project located on North Island
Almonty Industries: A smart play on Western tungsten independence Almonty Industries has taken a significant step forward in securing its future revenue stream and strategic relevance.
Brightstar hits 8g/t jackpot after infill work at Yundaga Brightstar Resources Ltd has received the final results from a program of infill drilling at the deposit, revealing high-grade intercepts
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.